Biocon Ltd.

₹330.75

Biocon Ltd.

₹330.75

₹330.75

-2.35 (-0.71%) - 24 May 2025 04:27 PM

About Company

Biocon Limited is engaged in the manufacture of biotechnology products and research services. It is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.

Market Cap. ₹ 39,710 Cr.
52 Week - High/Low ₹ 405/270
P/E Ratio 65.11
P/B Ratio 3.64
Enterprise Value ₹ 1,572 Cr.
ROE % 1.1
RSI Value 48.30
EMA 50 334.81
EMA 200 337.88
Market Cap. ₹ 39,710 Cr.
52 Week - High/Low ₹ 405/270
P/E Ratio 39.19
P/B Ratio 2.01
Enterprise Value ₹ 12,861 Cr.
ROE % 7.0
RSI Value 48.30
EMA 50 334.81
EMA 200 337.88

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.